Afridx

AfriDx is a consortium of partners developing a rapid diagnostics system for Covid-19 in Sub-Sarahan Africa, designed to be manufacturable in Africa to increase affordability, improve epidemic preparedness and strengthen local resilience. To deliver these aims and objectives we will: -Conduct a trial of a prototype POC LAMP (PATHPOD) for detection of viral RNA (SARS-Cov-2) in the COVID testing laboratories in Ghana. -Develop a production process for local manufacture in Ghana of the required biological materials at low cost and produce a version of PATHPOD in Africa for Africa (the AfriDx). -Screen and isolate scFv's for a serology antibody titre test, to produce an immunoassay (AfriMx) for late stage infection and post infection immunity. -Train skilled and minimally skilled personnel to understand and perform testing. -Connect with local enterprise in Ghana and develop a plan for exploitation and the route to market for the low cost AfriDX and AfriMx diagnostics. This project will give sub-Saharan Africa the technology, tools and training which will strengthen its capacities to manage outbreaks, both directly and through improved in country manufacturing capability for healthcare diagnostics. Socioeconomic long-term independence from external grant-aid to supply diagnostics and development of a local manufacturing infrastructure will emerge. AfriDx is funded by EDCTP and the European Union's Horizon 2020 research and innovation program under grant number RIA2020EF-2918.
Social Link - Linkedin: http://www. linkedin.com/company /afridx
Keywords: research services